{"hands_on_practices": [{"introduction": "When evaluating the success of infant mortality reduction strategies, comparing a local district's infant mortality rate ($IMR$) to a national average seems straightforward. However, such comparisons can be misleading if the underlying population structures differ, particularly in the distribution of high-risk preterm births. This exercise introduces the fundamental epidemiological technique of direct standardization, a method to adjust for these differences and enable a fair and accurate assessment of performance. Mastering this skill is crucial for correctly interpreting health data and evaluating the true impact of public health interventions. [@problem_id:4539533]", "problem": "A district introduced a bundle of evidence-based prenatal and neonatal interventions targeting preterm birth prevention and early-life care. To evaluate the district’s performance fairly against a national benchmark and to inform resource allocation for infant mortality reduction strategies, construct a gestational-age standardized Infant Mortality Rate (IMR), defined as the number of infant deaths per $1000$ live births during the first year of life, by direct standardization to the national gestational-age distribution. Use the following scientifically plausible data, collected over one calendar year:\n\nGestational-age strata for the district:\n- Very preterm ($34$ weeks): $420$ live births, $84$ infant deaths.\n- Moderate–late preterm ($34$–$36$ weeks): $1040$ live births, $52$ infant deaths.\n- Term ($37$–$41$ weeks): $7900$ live births, $63$ infant deaths.\n- Post-term ($\\ge 42$ weeks): $640$ live births, $10$ infant deaths.\n\nReference (national) gestational-age distribution of live births, expressed as proportions that sum to $1$:\n- Very preterm ($34$ weeks): $0.02$\n- Moderate–late preterm ($34$–$36$ weeks): $0.08$\n- Term ($37$–$41$ weeks): $0.87$\n- Post-term ($\\ge 42$ weeks): $0.03$\n\nConstruct the direct-standardized IMR for the district by applying the district’s stratum-specific infant mortality rates to the national gestational-age distribution. Express your final IMR in deaths per $1000$ live births. Round your answer to four significant figures.", "solution": "The problem is deemed valid as it is scientifically grounded in standard epidemiological methods, is well-posed with sufficient and consistent data, and is expressed in objective, formal language. There are no violations of the validation criteria.\n\nThe objective is to compute a direct-standardized Infant Mortality Rate (IMR) for a district, using the national gestational-age distribution as the standard population. Direct standardization is a method used to compare rates between two or more populations that have different underlying structural characteristics, such as age distribution. In this case, the structural characteristic is the distribution of live births by gestational age. The standardized rate represents the mortality rate that would be observed in the district if it had the same gestational-age distribution as the nation.\n\nLet the gestational-age strata be indexed by $i$, where $i=1$ for very preterm, $i=2$ for moderate–late preterm, $i=3$ for term, and $i=4$ for post-term.\n\nThe first step is to calculate the stratum-specific IMR for the district, denoted as $r_i$. The IMR is defined per $1000$ live births. The formula for $r_i$ is:\n$$ r_i = \\frac{D_i}{L_i} \\times 1000 $$\nwhere $D_i$ is the number of infant deaths and $L_i$ is the number of live births in stratum $i$ of the district.\n\nThe provided data for the district are:\n- Stratum $1$ (Very preterm, $34$ weeks): $D_1 = 84$, $L_1 = 420$.\n- Stratum $2$ (Moderate–late preterm, $34–36$ weeks): $D_2 = 52$, $L_2 = 1040$.\n- Stratum $3$ (Term, $37–41$ weeks): $D_3 = 63$, $L_3 = 7900$.\n- Stratum $4$ (Post-term, $\\ge 42$ weeks): $D_4 = 10$, $L_4 = 640$.\n\nCalculating the stratum-specific rates, $r_i$:\n- For stratum $1$:\n$$ r_1 = \\frac{84}{420} \\times 1000 = 0.2 \\times 1000 = 200 \\text{ deaths per } 1000 \\text{ live births} $$\n- For stratum $2$:\n$$ r_2 = \\frac{52}{1040} \\times 1000 = 0.05 \\times 1000 = 50 \\text{ deaths per } 1000 \\text{ live births} $$\n- For stratum $3$:\n$$ r_3 = \\frac{63}{7900} \\times 1000 = \\frac{630}{79} \\text{ deaths per } 1000 \\text{ live births} $$\n- For stratum $4$:\n$$ r_4 = \\frac{10}{640} \\times 1000 = \\frac{1000}{64} = \\frac{125}{8} = 15.625 \\text{ deaths per } 1000 \\text{ live births} $$\n\nNext, we use the national gestational-age distribution as the standard population. The proportions of live births in the national population, denoted as $P_i$, are given:\n- $P_1 = 0.02$\n- $P_2 = 0.08$\n- $P_3 = 0.87$\n- $P_4 = 0.03$\n\nThe direct-standardized IMR, denoted $\\text{IMR}_{\\text{std}}$, is calculated by taking the weighted sum of the stratum-specific rates, where the weights are the proportions from the standard population:\n$$ \\text{IMR}_{\\text{std}} = \\sum_{i=1}^{4} (r_i \\times P_i) $$\nThis calculation yields the total expected number of deaths per $1000$ individuals in a population with the standard structure.\n\nSubstituting the calculated rates and given proportions into the formula:\n$$ \\text{IMR}_{\\text{std}} = (r_1 \\times P_1) + (r_2 \\times P_2) + (r_3 \\times P_3) + (r_4 \\times P_4) $$\n$$ \\text{IMR}_{\\text{std}} = (200 \\times 0.02) + (50 \\times 0.08) + \\left(\\frac{630}{79} \\times 0.87\\right) + (15.625 \\times 0.03) $$\n\nNow, we compute each term:\n- Contribution from stratum $1$: $200 \\times 0.02 = 4.0$\n- Contribution from stratum $2$: $50 \\times 0.08 = 4.0$\n- Contribution from stratum $3$: $\\frac{630}{79} \\times 0.87 = \\frac{548.1}{79} \\approx 6.93797468$\n- Contribution from stratum $4$: $15.625 \\times 0.03 = 0.46875$\n\nSumming these contributions gives the standardized IMR:\n$$ \\text{IMR}_{\\text{std}} = 4.0 + 4.0 + \\frac{548.1}{79} + 0.46875 $$\n$$ \\text{IMR}_{\\text{std}} = 8.0 + 6.93797468... + 0.46875 $$\n$$ \\text{IMR}_{\\text{std}} = 15.40672468... $$\n\nThe problem requires the final answer to be rounded to four significant figures. The calculated value is $15.40672468...$. The first four significant figures are $1$, $5$, $4$, and $0$. The fifth significant figure is $6$, which is greater than or equal to $5$, so we round up the fourth significant figure. The digit $0$ is rounded up to $1$.\nTherefore, the standardized IMR, rounded to four significant figures, is $15.41$.", "answer": "$$ \\boxed{15.41} $$", "id": "4539533"}, {"introduction": "Identifying a problem like a high rate of neonatal sepsis is only the first step; the real challenge lies in implementing effective and sustainable solutions. This practice immerses you in the Quality Improvement (QI) process by asking you to design a Plan-Do-Study-Act (PDSA) cycle, a core methodology for testing changes in a real-world clinical setting. By working through this scenario, you will learn to define meaningful outcome and balancing measures and apply statistical process control thinking to determine if an intervention is truly making a difference. [@problem_id:4539520]", "problem": "A district hospital with approximately $1200$ live births per year seeks to reduce neonatal sepsis to lower infant mortality. The Quality Improvement (QI) team will use a Plan-Do-Study-Act (PDSA) cycle. Baseline surveillance shows culture-confirmed early-onset neonatal sepsis incidence of approximately $18$ cases per $1000$ live births. The team will collect data weekly. Select the option that most appropriately specifies a PDSA cycle for reducing neonatal sepsis using scientifically sound outcome and balancing measures and an analysis plan with an achievable and valid timeline for detection of change. The correct option must define: a clear aim and a focused change package, at least one primary outcome measure with a correct denominator, at least two balancing measures that address unintended consequences, a data collection plan including sufficient baseline to estimate a center line, and a statistically defensible rule and minimum timeline to detect nonrandom change in weekly data.\n\nA. Plan: Install alcohol-based hand rub (ABHR) at every cot and entry, retrain staff on aseptic technique for intravenous line insertion, standardize neonatal sepsis screening, and implement a protocol to administer first-dose antibiotics within $60$ minutes of recognition. Do: Pilot in the Neonatal Intensive Care Unit (NICU) for $6$ weeks with weekly audits. Study: Primary outcome is culture-confirmed early-onset neonatal sepsis incidence per $1000$ live births ($\\le 7$ days of life). Process measures include hand hygiene compliance proportion and median time-to-first-dose antibiotics (minutes). Balancing measures include blood culture contamination rate per $100$ cultures, antibiotic days per $100$ neonate-days, exclusive breastfeeding at discharge proportion, and staff overtime hours per week. Analysis plan: Collect $12$ consecutive baseline weekly points to estimate the median, then use Statistical Process Control (SPC) run chart rules to signal a shift defined as $\\ge 6$ consecutive weekly points below the baseline median; minimum time to detect is $12 + 6 = 18$ weeks, with additional assessment of antimicrobial resistance quarterly. Act: If a sustained shift is observed, spread bundle hospital-wide; if not, refine training and supply chain.\n\nB. Plan: Start empiric prophylactic antibiotics in all neonates during the first $48$ hours of life. Do: Implement hospital-wide immediately. Study: Primary outcome is overall neonatal mortality per $100$ total hospital admissions. No balancing measures are collected. Analysis plan: Compare mean mortality in the $2$ weeks before and $2$ weeks after implementation; detect change if any decrease is observed. Act: Continue prophylaxis if mortality drops.\n\nC. Plan: Intensify sepsis screening by ordering routine blood cultures for all febrile neonates and increase laboratory throughput. Do: Implement in all neonatal wards. Study: Primary outcome is neonatal sepsis case fatality proportion defined as $\\frac{\\text{sepsis deaths}}{\\text{sepsis cases}}$. Balancing measures are not specified. Analysis plan: Aggregate monthly data and declare improvement if $\\ge 3$ consecutive months show lower case fatality proportion than the previous $3$ months; the expected timeline is $3$ months. Act: If a decrease is seen, continue screening.\n\nD. Plan: Provide intrapartum antibiotic prophylaxis to all laboring mothers irrespective of Group B Streptococcus (GBS) status, and expand antibiotic formulary. Do: Implement across all maternity wards. Study: Primary outcome is suspected neonatal sepsis rate per $1000$ neonatal admissions. Balancing measures include antimicrobial resistance rates in the laboratory antibiogram and length of stay. Analysis plan: Use monthly run charts and detect change when $3$ consecutive months fall below the baseline average; expected timeline is $4$ months. Act: Maintain expanded prophylaxis if rates fall.\n\nWhich option is best aligned with preventive medicine principles and valid QI methodology for detecting change in neonatal sepsis incidence in weekly data while safeguarding against unintended harms?\n\nA. The PDSA cycle with focused infection prevention changes, a valid incidence outcome per $1000$ live births, multiple balancing measures, and a run chart shift rule requiring $\\ge 6$ consecutive weekly points after $12$ weeks baseline.\n\nB. The universal neonatal prophylaxis approach with a mortality outcome per $100$ total hospital admissions and a $2$-week before-after comparison.\n\nC. The screening-focused approach with a case fatality proportion and a $3$-month monthly detection rule.\n\nD. The universal maternal intrapartum prophylaxis for all, with suspected sepsis per $1000$ admissions and a $3$-month monthly detection rule.", "solution": "The problem statement has been validated and is determined to be a valid, well-posed question grounded in the principles of clinical quality improvement (QI) and preventive medicine. It provides sufficient, consistent, and scientifically sound information to evaluate the provided options against the stated criteria.\n\nThis problem requires the evaluation of four proposed Plan-Do-Study-Act (PDSA) cycles for reducing neonatal sepsis in a district hospital. The evaluation must be based on established QI principles, specifically concerning the design of the intervention (Plan), the choice of measures (Study), and the data analysis strategy (Study/Act). A sound QI project must have:\n1.  A focused, evidence-based intervention (change package).\n2.  A specific, measurable, attainable, relevant, and time-bound (SMART) aim, reflected in a primary outcome measure with a valid denominator.\n3.  Balancing measures to monitor for unintended negative consequences.\n4.  A robust data collection and analysis plan using time-series data (e.g., run charts or statistical process control charts) to distinguish between random variation and signals of real change, which requires an adequate baseline period.\n\nThe given baseline data are approximately $1200$ live births per year and a neonatal sepsis incidence of $18$ cases per $1000$ live births. This translates to $1200 \\times (18/1000) = 21.6$ cases per year, or approximately $21.6 / 52 \\approx 0.415$ cases per week. This low weekly count is a critical detail for evaluating the proposed statistical analysis plans.\n\n**Analysis of Option A**\n\n- **Plan**: The proposed change is a \"bundle\" of four high-impact, evidence-based practices: alcohol-based hand rub (ABHR) installation, aseptic technique retraining, standardized screening, and a \"time-to-antibiotics\" protocol. This represents a focused, scientifically sound approach to infection prevention and control.\n- **Do**: Piloting the change in a specific unit (the NICU) for a defined period ($6$ weeks) is a classic PDSA approach, allowing for testing on a small scale before hospital-wide implementation.\n- **Study**:\n    - **Primary Outcome Measure**: \"culture-confirmed early-onset neonatal sepsis incidence per $1000$ live births\". This is the gold standard measure for this goal. It is specific (\"culture-confirmed\") and uses the correct denominator for an incidence rate (\"per $1000$ live births\").\n    - **Process Measures**: Hand hygiene compliance and time-to-antibiotics measure whether the new processes are being followed, which is crucial for interpreting the outcome data.\n    - **Balancing Measures**: Four are listed: blood culture contamination rate, antibiotic days per $100$ neonate-days, exclusive breastfeeding proportion, and staff overtime. This is a comprehensive set of measures that addresses key potential unintended consequences: increased false positives (contamination), overuse of antibiotics, negative impact on family-centered care (breastfeeding), and staff burnout. This far exceeds the minimum requirement of two.\n    - **Analysis Plan**: The plan specifies collecting $12$ weekly baseline points to establish the process center line (median). It proposes using a Statistical Process Control (SPC) run chart and a standard rule for detecting a shift: $\\ge 6$ consecutive points on one side of the median. This is a statistically valid method for analyzing time-series data in QI. The calculated minimum timeline of $12$ (baseline) + $6$ (signal) = $18$ weeks is realistic and methodologically derived.\n- **Critique**: There is a subtle technical issue with the specified run chart rule. With an expected weekly case count of $\\approx 0.4$, the probability of a week having zero cases is high ($P(0) = e^{-0.415} \\approx 0.66$). Therefore, the median weekly case count (and rate) will be $0$. A rule requiring \"$\\ge 6$ consecutive weekly points *below* the baseline median\" is impossible to satisfy if the median is $0$. A better chart for such rare event data would be a g-chart (time between events), or the run chart rule would need to be adapted (e.g., looking for an unusually long run of zero-case weeks). However, despite this minor mis-specification of the rule, the overall framework—using a run chart with a defined baseline and a statistical rule for detecting change—is fundamentally correct and vastly superior to the other options.\n\n**Verdict**: **Correct**. This option describes a well-designed, robust, and safe QI project that aligns with best practices in preventive medicine and QI methodology. Its minor technical flaw in specifying the run chart rule is insignificant compared to the fundamental, critical errors in the other options.\n\n**Analysis of Option B**\n\n- **Plan**: The intervention is to \"start empiric prophylactic antibiotics in all neonates\". This is a radical, non-evidence-based, and potentially dangerous strategy. Universal antibiotic prophylaxis carries significant risks, including the promotion of antimicrobial resistance, disruption of the neonatal microbiome with potential long-term health consequences, and adverse drug reactions. It contradicts the principles of antimicrobial stewardship.\n- **Study**:\n    - **Primary Outcome Measure**: \"overall neonatal mortality per $100$ total hospital admissions\". First, mortality is a less sensitive measure than sepsis incidence. Second, and more critically, the denominator \"per $100$ total hospital admissions\" is incorrect and nonsensical, as it includes adult and other non-neonatal admissions, which would obscure any real effect. The correct denominator is per $1000$ live births or neonatal admissions.\n    - **Balancing Measures**: \"No balancing measures are collected.\" This is a catastrophic omission. For an intervention with such high potential for harm (especially antimicrobial resistance), failing to monitor for unintended consequences is unethical and unacceptable.\n    - **Analysis Plan**: A simple before-after comparison of mean mortality over two $2$-week periods is statistically invalid. It completely fails to account for normal process variation (common cause variation). Any observed difference would be uninterpretable and highly likely to be due to random chance.\n\n**Verdict**: **Incorrect**. This option is flawed in every aspect: the intervention is dangerous, the outcome measure is invalid, balancing measures are absent, and the analysis plan is statistically indefensible. This plan represents medical and statistical malpractice.\n\n**Analysis of Option C**\n\n- **Plan**: The focus is on intensified screening and lab throughput. While potentially beneficial, this is a detection and treatment strategy, not a primary prevention strategy to \"reduce neonatal sepsis\" incidence as per the main goal.\n- **Study**:\n    - **Primary Outcome Measure**: \"neonatal sepsis case fatality proportion\". This measures the proportion of babies with sepsis who die ($\\frac{\\text{sepsis deaths}}{\\text{sepsis cases}}$). This is a measure of treatment effectiveness, not sepsis incidence. It is a mismatch for the stated problem goal.\n    - **Balancing Measures**: \"Balancing measures are not specified.\" This is a critical failure. Increased screening can lead to over-diagnosis, increased costs, and unnecessary antibiotic use, all of which must be monitored.\n    - **Analysis Plan**: Aggregating weekly data into monthly data results in a loss of information and delays learning. The rule \"$\\ge 3$ consecutive months show lower case fatality proportion than the previous $3$ months\" is not a standard SPC rule and is a poor method for detecting change, as it is a simplistic before-after comparison that is not robust to random variation.\n\n**Verdict**: **Incorrect**. This option fails due to a mismatched primary outcome measure, a lack of balancing measures, and a weak, non-standard analysis plan.\n\n**Analysis of Option D**\n\n- **Plan**: \"Provide intrapartum antibiotic prophylaxis to all laboring mothers\". Similar to Option B, this is an overly broad, non-risk-stratified intervention that goes against evidence-based guidelines for GBS prophylaxis and principles of antimicrobial stewardship.\n- **Study**:\n    - **Primary Outcome Measure**: \"suspected neonatal sepsis rate per $1000$ neonatal admissions\". \"Suspected\" sepsis is a subjective and unreliable measure. A QI initiative could inadvertently increase the rate of \"suspected\" sepsis simply by raising awareness, even if the true incidence decreases. The gold standard is \"culture-confirmed\" sepsis, as used in the baseline data and in Option A.\n    - **Balancing Measures**: \"antimicrobial resistance rates\" and \"length of stay\" are listed. These are appropriate and important balancing measures, so this option does satisfy this single criterion.\n    - **Analysis Plan**: The plan uses monthly run charts, which is suboptimal compared to using the available weekly data. The rule \"detect change when $3$ consecutive months fall below the baseline average\" is a weak, non-standard run chart rule that has a higher likelihood of signaling a false positive compared to the rule of $6$ (or more) consecutive points. A baseline period is not explicitly defined.\n\n**Verdict**: **Incorrect**. While it correctly includes balancing measures, the intervention is unsound, the primary outcome measure is weak and subjective, and the analysis plan is suboptimal and uses a weak statistical rule.\n\n**Conclusion**\nOption A is unequivocally the \"best aligned\" and \"most appropriate\" choice. It is the only option that presents a scientifically sound and ethically responsible QI project. It features an evidence-based intervention, a valid and specific primary outcome measure, a comprehensive set of balancing measures, and a robust statistical plan for detecting change using standard QI tools. The flaws in options B, C, and D are fundamental and disqualify them entirely.", "answer": "$$\\boxed{A}$$", "id": "4539520"}, {"introduction": "In the real world, choosing which public health programs to fund is a complex decision involving multiple competing priorities like effectiveness, cost, equity, and feasibility. This exercise introduces Multi-Criteria Decision Analysis (MCDA), a powerful and transparent framework for making these tough choices. This practice will equip you with a quantitative method to formalize decision-making, ensuring that priorities are weighed logically and transparently to maximize overall public health value within a given budget. [@problem_id:4539492]", "problem": "A public health team is prioritizing a package of interventions to reduce infant mortality in a district with $10{,}000$ annual live births and a baseline infant mortality rate of $40$ per $1000$ live births (baseline expected infant deaths $=400$). Four candidate interventions are considered, each characterized by expected annual infant deaths averted (effectiveness), the proportion of benefits accruing to underserved populations (equity), a probability of successful implementation (feasibility), and annual cost in United States dollars (USD). The interventions are:\n\n- Intervention $\\mathrm{I1}$ (Exclusive breastfeeding promotion): expected deaths averted $48$, equity $0.55$, feasibility $0.70$, annual cost $\\$200{,}000$.\n- Intervention $\\mathrm{I2}$ (Community-based newborn care): expected deaths averted $36$, equity $0.80$, feasibility $0.65$, annual cost $\\$300{,}000$.\n- Intervention $\\mathrm{I3}$ (Kangaroo mother care): expected deaths averted $30$, equity $0.70$, feasibility $0.90$, annual cost $\\$180{,}000$.\n- Intervention $\\mathrm{I4}$ (Clean birth kits): expected deaths averted $26$, equity $0.85$, feasibility $0.85$, annual cost $\\$160{,}000$.\n\nThe team will select any non-empty package (subset) of these interventions whose total cost does not exceed the annual budget $B=\\$500{,}000$. For a given package, define the following raw criterion values:\n- Package effectiveness $E_{\\mathrm{pkg}}$ as the sum of expected deaths averted over included interventions.\n- Package equity $Q_{\\mathrm{pkg}}$ as the impact-weighted equity, computed as the sum over included interventions of expected deaths averted times equity, divided by $E_{\\mathrm{pkg}}$.\n- Package feasibility $F_{\\mathrm{pkg}}$ as the arithmetic mean of feasibility scores over included interventions.\n- Package cost $C_{\\mathrm{pkg}}$ as the sum of costs over included interventions.\n\nUse a multi-criteria decision analysis (MCDA) with the following criterion weights: effectiveness $w_{E}=0.45$, equity $w_{Q}=0.25$, feasibility $w_{F}=0.20$, and cost $w_{C}=0.10$. To aggregate criteria into a single priority score, first normalize each raw criterion across the set of all feasible packages by applying a monotonic transformation that maps the minimum observed value to $0$ and the maximum observed value to $1$ for that criterion. For effectiveness, equity, and feasibility (benefit-type criteria), use a transformation that increases with the raw value; for cost (cost-type criterion), use a transformation that decreases with the raw value.\n\nCompute the aggregated weighted score for each feasible package using the specified weights, identify the package with the highest aggregated score, and report the maximum aggregated score. Round your answer to four significant figures and express it as a dimensionless number. Do not report the package composition; report only the maximum aggregated score.", "solution": "The problem statement has been validated and is deemed valid. It presents a well-posed multi-criteria decision analysis (MCDA) problem with all necessary data, constraints, and objective functions clearly defined. The problem is scientifically grounded in public health and operations research principles.\n\nThe solution process involves several steps:\n1.  Identify all feasible packages of interventions that satisfy the budget constraint.\n2.  Calculate the raw values for the four criteria (effectiveness, equity, feasibility, cost) for each feasible package.\n3.  Normalize these raw criterion values across all feasible packages.\n4.  Compute the aggregated weighted score for each package.\n5.  Identify the package with the maximum score.\n\nThe four interventions are:\n- Intervention $\\mathrm{I1}$: $E_1=48$, $Q_1=0.55$, $F_1=0.70$, $C_1=\\$200,000$.\n- Intervention $\\mathrm{I2}$: $E_2=36$, $Q_2=0.80$, $F_2=0.65$, $C_2=\\$300,000$.\n- Intervention $\\mathrm{I3}$: $E_3=30$, $Q_3=0.70$, $F_3=0.90$, $C_3=\\$180,000$.\n- Intervention $\\mathrm{I4}$: $E_4=26$, $Q_4=0.85$, $F_4=0.85$, $C_4=\\$160,000$.\n\nThe total budget is $B = \\$500,000$.\n\n**Step 1: Identify Feasible Packages**\nThere are $2^4 - 1 = 15$ non-empty subsets (packages) of the four interventions. We evaluate the total cost $C_{\\mathrm{pkg}}$ for each and compare it to the budgetjaw $B$.\n\n- Single interventions: $\\{\\mathrm{I1}\\}, \\{\\mathrm{I2}\\}, \\{\\mathrm{I3}\\}, \\{\\mathrm{I4}\\}$ are all feasible as their individual costs ($200,000$, $300,000$, $180,000$, $160,000$) are within the budget.\n- Pairs of interventions:\n  - $\\{\\mathrm{I1}, \\mathrm{I2}\\}$: $C = 200,000 + 300,000 = \\$500,000$ (Feasible)\n  - $\\{\\mathrm{I1}, \\mathrm{I3}\\}$: $C = 200,000 + 180,000 = \\$380,000$ (Feasible)\n  - $\\{\\mathrm{I1}, \\mathrm{I4}\\}$: $C = 200,000 + 160,000 = \\$360,000$ (Feasible)\n  - $\\{\\mathrm{I2}, \\mathrm{I3}\\}$: $C = 300,000 + 180,000 = \\$480,000$ (Feasible)\n  - $\\{\\mathrm{I2}, \\mathrm{I4}\\}$: $C = 300,000 + 160,000 = \\$460,000$ (Feasible)\n  - $\\{\\mathrm{I3}, \\mathrm{I4}\\}$: $C = 180,000 + 160,000 = \\$340,000$ (Feasible)\n- Triplets of interventions:\n  - $\\{\\mathrm{I1}, \\mathrm{I2}, \\mathrm{I3}\\}$: $C = 200,000 + 300,000 + 180,000 = \\$680,000$ (Not feasible)\n  - All other triplets and the quadruplet have costs exceeding the budget.\n\nThere are $10$ feasible packages.\n\n**Step 2: Calculate Raw Criterion Values**\nFor each of the $10$ feasible packages, we calculate the four criterion values: $E_{\\mathrm{pkg}}, Q_{\\mathrm{pkg}}, F_{\\mathrm{pkg}}, C_{\\mathrm{pkg}}$. The values are tabulated below. Note that $Q_{\\mathrm{pkg}} = \\frac{\\sum E_i Q_i}{\\sum E_i}$ and $F_{\\mathrm{pkg}}$ is the arithmetic mean of the feasibilities of the interventions in the package.\n\n| Package                        | $C_{\\mathrm{pkg}}$ (\\$) | $E_{\\mathrm{pkg}}$ | $Q_{\\mathrm{pkg}}$ | $F_{\\mathrm{pkg}}$ |\n|--------------------------------|-------------------------|--------------------|--------------------|--------------------|\n| P1: $\\{\\mathrm{I1}\\}$          | $200,000$               | $48$               | $0.5500$           | $0.700$            |\n| P2: $\\{\\mathrm{I2}\\}$          | $300,000$               | $36$               | $0.8000$           | $0.650$            |\n| P3: $\\{\\mathrm{I3}\\}$          | $180,000$               | $30$               | $0.7000$           | $0.900$            |\n| P4: $\\{\\mathrm{I4}\\}$          | $160,000$               | $26$               | $0.8500$           | $0.850$            |\n| P5: $\\{\\mathrm{I1, I2}\\}$      | $500,000$               | $84$               | $0.6571$           | $0.675$            |\n| P6: $\\{\\mathrm{I1, I3}\\}$      | $380,000$               | $78$               | $0.6077$           | $0.800$            |\n| P7: $\\{\\mathrm{I1, I4}\\}$      | $360,000$               | $74$               | $0.6554$           | $0.775$            |\n| P8: $\\{\\mathrm{I2, I3}\\}$      | $480,000$               | $66$               | $0.7545$           | $0.775$            |\n| P9: $\\{\\mathrm{I2, I4}\\}$      | $460,000$               | $62$               | $0.8210$           | $0.750$            |\n| P10: $\\{\\mathrm{I3, I4}\\}$     | $340,000$               | $56$               | $0.7696$           | $0.875$            |\n\n**Step 3: Normalize Criterion Values**\nFirst, we find the minimum and maximum values for each criterion across the set of feasible packages.\n- Effectiveness ($E$): $E_{\\min} = 26$ (P4), $E_{\\max} = 84$ (P5). $\\Delta E = 58$.\n- Equity ($Q$): $Q_{\\min} = 0.5500$ (P1), $Q_{\\max} = 0.8500$ (P4). $\\Delta Q = 0.30$.\n- Feasibility ($F$): $F_{\\min} = 0.650$ (P2), $F_{\\max} = 0.900$ (P3). $\\Delta F = 0.25$.\n- Cost ($C$): $C_{\\min} = \\$160,000$ (P4), $C_{\\max} = \\$500,000$ (P5). $\\Delta C = \\$340,000$.\n\nThe normalization formulas are:\n- For $E, Q, F$ (benefit criteria): $X'_{\\mathrm{pkg}} = \\frac{X_{\\mathrm{pkg}} - X_{\\min}}{X_{\\max} - X_{\\min}}$\n- For $C$ (cost criterion): $C'_{\\mathrm{pkg}} = \\frac{C_{\\max} - C_{\\mathrm{pkg}}}{C_{\\max} - C_{\\min}}$\n\nThe normalized scores for each package are calculated as follows:\n\n| Pkg | $E'_{\\mathrm{pkg}}$ | $Q'_{\\mathrm{pkg}}$ | $F'_{\\mathrm{pkg}}$ | $C'_{\\mathrm{pkg}}$ |\n|-----|---------------------|---------------------|---------------------|---------------------|\n| P1  | $0.3793$            | $0.0000$            | $0.2000$            | $0.8824$            |\n| P2  | $0.1724$            | $0.8333$            | $0.0000$            | $0.5882$            |\n| P3  | $0.0690$            | $0.5000$            | $1.0000$            | $0.9412$            |\n| P4  | $0.0000$            | $1.0000$            | $0.8000$            | $1.0000$            |\n| P5  | $1.0000$            | $0.3571$            | $0.1000$            | $0.0000$            |\n| P6  | $0.8966$            | $0.1923$            | $0.6000$            | $0.3529$            |\n| P7  | $0.8276$            | $0.3514$            | $0.5000$            | $0.4118$            |\n| P8  | $0.6897$            | $0.6818$            | $0.5000$            | $0.0588$            |\n| P9  | $0.6207$            | $0.9032$            | $0.4000$            | $0.1176$            |\n| P10 | $0.5172$            | $0.7321$            | $0.9000$            | $0.4706$            |\n\n**Step 4: Compute Aggregated Weighted Scores**\nThe aggregated score $S_{\\mathrm{pkg}}$ for each package is computed using the weights $w_E=0.45$, $w_Q=0.25$, $w_F=0.20$, $w_C=0.10$.\n$S_{\\mathrm{pkg}} = w_E E'_{\\mathrm{pkg}} + w_Q Q'_{\\mathrm{pkg}} + w_F F'_{\\mathrm{pkg}} + w_C C'_{\\mathrm{pkg}}$\n\n- $S_1 = 0.45(0.3793) + 0.25(0.0000) + 0.20(0.2000) + 0.10(0.8824) \\approx 0.2989$\n- $S_2 = 0.45(0.1724) + 0.25(0.8333) + 0.20(0.0000) + 0.10(0.5882) \\approx 0.3447$\n- $S_3 = 0.45(0.0690) + 0.25(0.5000) + 0.20(1.0000) + 0.10(0.9412) \\approx 0.4502$\n- $S_4 = 0.45(0.0000) + 0.25(1.0000) + 0.20(0.8000) + 0.10(1.0000) \\approx 0.5100$\n- $S_5 = 0.45(1.0000) + 0.25(0.3571) + 0.20(0.1000) + 0.10(0.0000) \\approx 0.5593$\n- $S_6 = 0.45(0.8966) + 0.25(0.1923) + 0.20(0.6000) + 0.10(0.3529) \\approx 0.6068$\n- $S_7 = 0.45(0.8276) + 0.25(0.3514) + 0.20(0.5000) + 0.10(0.4118) \\approx 0.6014$\n- $S_8 = 0.45(0.6897) + 0.25(0.6818) + 0.20(0.5000) + 0.10(0.0588) \\approx 0.5867$\n- $S_9 = 0.45(0.6207) + 0.25(0.9032) + 0.20(0.4000) + 0.10(0.1176) \\approx 0.5969$\n- $S_{10} = 0.45(0.5172) + 0.25(0.7321) + 0.20(0.9000) + 0.10(0.4706) \\approx 0.6429$\n\n**Step 5: Identify the Maximum Score**\nComparing the aggregated scores for all $10$ feasible packages, the maximum score is for package P10.\n$S_{\\max} = S_{10} \\approx 0.64285$\n\nThe question requires the answer rounded to four significant figures.\n$S_{\\max} \\approx 0.6429$.", "answer": "$$\\boxed{0.6429}$$", "id": "4539492"}]}